On May 17, Dr. Funamoto delivered lecture under the title of “Cancer treatment by activated autologous lymphocytes for the patients in the world” in the 14th Annual Meeting of Chinese Society of Cancer Biotherapy held May 17, 2015 in Beijing, China at the Beiging Conference Center. About 300 physicians providing cancer treatment and researchers from all over China audited the lecture at the site, and gained a better understanding of safety and efficacy of activated autologous lymphocytes in cancer treatment.
We are proceeding discussions with some hospitals and companies overseas to transfer the technology for the lymphocyte therapy because Lymphotec Inc. hopes that the activated autologous lymphocytes can be used by cancer patients around the world. Therefore, we would also like to continue to have an active involvement in cancer academic meetings overseas.